MYCO-004
Psychedelic drug
From Wikipedia, the free encyclopedia
MYCO-004 is a patch-delivered psychedelic tryptamine which is under development for the treatment of psychiatric disorders.[2][3][1] It is anticipated to allow for precision dosing and to have a short duration of approximately 2 hours.[4] The drug is being developed by Mydecine.[2][3] As of December 2021, it is in preclinical research for psychiatric disorders.[2][3] The exact chemical structure of MYCO-004 does not yet seem to have been disclosed.[2]
Other namesMYCO004
| Clinical data | |
|---|---|
| Other names | MYCO004 |
| Routes of administration | Transdermal (patch)[1] |
| Drug class | Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen |